Log In
Print
BCIQ
Print
Print this Print this
 

Viaskin HDM

  Manage Alerts
Collapse Summary General Information
Company DBV Technologies
DescriptionProteins delivered epicutaneously Viaskin patch technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat house dust mite allergy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today